Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
A8MT69
UPID:
CENPX_HUMAN
Alternative names:
FANCM-associated histone fold protein 2; FANCM-interacting histone fold protein 2; Fanconi anemia-associated polypeptide of 10 kDa; Retinoic acid-inducible gene D9 protein homolog; Stimulated by retinoic acid gene 13 protein homolog
Alternative UPACC:
A8MT69; O00281; O00282; Q96DD4; Q96F51
Background:
Centromere protein X, also known as FANCM-associated histone fold protein 2, plays a pivotal role in DNA repair and chromosomal stability. It is a key component of the Fanconi anemia (FA) core complex, essential for the FA pathway's activation in response to DNA damage. This protein, in collaboration with CENPS, CENPT, and CENPW, is crucial for kinetochore-microtubule attachment and mitotic progression.
Therapeutic significance:
Understanding the role of Centromere protein X could open doors to potential therapeutic strategies.